ECFVX
Price
$19.64
Change
+$0.08 (+0.41%)
Updated
Jul 3 closing price
Net Assets
237.77M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

ECFVX vs VVIAX

Header iconECFVX vs VVIAX Comparison
Open Charts ECFVX vs VVIAXBanner chart's image
Eaton Vance Focused Value Opps C
Price$19.64
Change+$0.08 (+0.41%)
VolumeN/A
Net Assets237.77M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
ECFVX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
ECFVX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ECFVX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. ECFVX (238M). VVIAX pays higher dividends than ECFVX: VVIAX (2.18) vs ECFVX (0.46). ECFVX was incepted earlier than VVIAX: ECFVX (14 years) vs VVIAX (25 years). ECFVX (1.79) is less costly to investors than VVIAX (0.05). ECFVX is a more actively managed with annual turnover of: 88.00 vs. VVIAX (9.00). ECFVX has a lower initial minimum investment than VVIAX: ECFVX (1000) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. ECFVX (1.53). VVIAX return over 5 years is better than : 80.13 vs. ECFVX (40.96).
ECFVXVVIAXECFVX / VVIAX
Total Expense Ratio1.740.053,480%
Annual Report Gross Expense Ratio1.790.053,580%
Fund Existence14 years25 years-
Gain YTD2.9356.19847%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets238M189B0%
Annual Yield % from dividends0.462.1821%
Returns for 1 year1.5312.0313%
Returns for 3 years15.3735.1744%
Returns for 5 years40.9680.1351%
Returns for 10 years46.30115.6740%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.